Viewing Study NCT02955212


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2026-03-29 @ 3:28 PM
Study NCT ID: NCT02955212
Status: COMPLETED
Last Update Posted: 2021-09-27
First Post: 2016-11-02
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)
Sponsor: AbbVie
Organization: